Category: Clinical oncology

CAR-T cell therapy shows promising results in cancer treatments, however, in terms of treating Hodgkin’s lymphoma it is considered an option when patients relapse or experience primary refractory disease. CAR-T cell therapy is considered a good alternative to regular treatment as the safety is high and, at the same time, it makes many patients respond…